5. Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) offers exposure to home-based care for patients with complex medical needs. Its second-quarter 2026 revenue increased 13.7% to $670.5 million, while adjusted EBITDA rose 8% to $95.4 million. Management also increased its full-year revenue guidance to more than $2.68 billion. ir.aveanna.com
Those figures show expanding demand, but they also reveal an issue investors should examine. Adjusted EBITDA grew more slowly than revenue, meaning higher sales did not produce a matching rate of growth in that earnings measure.
The appeal is its expanding home-care business and potential operating improvements. However, the supplied evidence does not establish a material AI product or AI revenue stream. That limits its ranking in an article focused on artificial intelligence in healthcare.
